4//SEC Filing
Kayyem Jon Faiz 4
Accession 0002007919-24-000064
CIK 0002007919other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:03 PM ET
Size
11.1 KB
Accession
0002007919-24-000064
Insider Transaction Report
Form 4
Kayyem Jon Faiz
Director
Transactions
- Purchase
Common Stock
2024-11-19$14.23/sh+34,843$495,708→ 51,093 total(indirect: By Children) - Purchase
Common Stock
2024-11-19$14.23/sh+34,843$495,708→ 51,093 total(indirect: By Children) - Purchase
Common Stock
2024-11-20$14.19/sh+18,750$266,102→ 69,843 total(indirect: By Children) - Purchase
Common Stock
2024-11-20$14.19/sh+18,750$266,102→ 69,843 total(indirect: By Children)
Footnotes (4)
- [F1]The shares were purchased in multiple transactions at prices ranging from $14.09 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
- [F3]These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
- [F4]The shares were purchased in multiple transactions at prices ranging from $13.93 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeother
Related Parties
1- filerCIK 0001366268
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:03 PM ET
- Size
- 11.1 KB